A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation

CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023 - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …

Advances in structure-based drug discovery of carbonic anhydrase inhibitors

CT Supuran - Expert opinion on drug discovery, 2017 - Taylor & Francis
Introduction: The enzyme carbonic anhydrase (CA, EC 4.2. 1.1) is found in numerous
organisms across the tree of life, with seven distinct classes known to date. CA inhibition can …

Profound Methyl Effects in Drug Discovery and a Call for New C H Methylation Reactions

H Schönherr, T Cernak - Angewandte Chemie International …, 2013 - Wiley Online Library
The methyl group is one of the most commonly occurring carbon fragments in small‐
molecule drugs. This simplest alkyl fragment appears in more than 67% of the top‐selling …

Bacterial, fungal and protozoan carbonic anhydrases as drug targets

C Capasso, CT Supuran - Expert opinion on therapeutic targets, 2015 - Taylor & Francis
Introduction: The carbonic anhydrases (CAs, EC 4.2. 1.1), a group of ubiquitously expressed
metalloenzymes, are involved in numerous physiological and pathological processes, as …

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

CT Supuran - Future medicinal chemistry, 2011 - Taylor & Francis
Carbonic anhydrases (CAs, Enzyme Commission number 4.2. 1.1) catalyze a simple but
fundamental reaction, CO2 hydration to yield bicarbonate and protons. CAs belonging to the …

Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing

VM Dembitsky, AAA Al Quntar, M Srebnik - Chemical Reviews, 2011 - ACS Publications
Chemical communication is a phenomenon exhibited by many different organisms and
nowadays is one of the most prominent research areas at the chemistry-microbiology …

Boron-containing carbonic anhydrases inhibitors

S Giovannuzzi, A Nikitjuka, BRP Resende… - Bioorganic …, 2024 - Elsevier
Over the last decades, the medicinal chemistry of boron-based compounds has been
extensively explored, designing valuable small molecule drugs to tackle diseases and …

Benzoxaborole as a new chemotype for carbonic anhydrase inhibition

V Alterio, R Cadoni, D Esposito, D Vullo… - Chemical …, 2016 - pubs.rsc.org
In this paper we report the synthesis of a series of benzoxaborole derivatives, their inhibition
properties against some carbonic anhydrases (CAs), recognized as important drug targets …

[HTML][HTML] From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease

DC Gomes, TS Medeiros, EL Alves Pereira… - International Journal of …, 2023 - mdpi.com
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …

Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis

L Syrjänen, AB Vermelho… - Journal of Medicinal …, 2013 - ACS Publications
Leishmaniasis is an infection provoked by protozoans belonging to the genus Leishmania.
Among the many species and subsepecies of such protozoa, Leishmania donovani chagasi …